UK 05:19 Saturday, 24 October 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
In March, the struck off dentist Ajan Rejinald announced that Roquefort Therapeutics (ROQ) was to sell its Oncogeni subsidiary for up to $12 million to Nations Trust Holding LLC. In May we were told the deal would complete in June. It has not and there has been no RNS. I wonder: does Nations Trust Holding LLC actually exist at all?
Roquefort Therapeutics (ROQ) stated in May that the sale of Oncogeni Ltd would see a binding SPA signed in June with completion for up to $12 million “shortly thereafter”. As I flagged up to the FCA yesterday there has been no RNS since June to confirm this or to flag up a problem. So, what does Companies House say?
It would be rude not to write. The FCA should be forcing shitco Roquefort Investments (ROQ) into issuing an RNS. The letter, winged off electronically just now, reads
Only a moron would own shares in Roquefort (ROQ), the pharma company created by the disgraced struck off dentist Ajan Rejinald. But even morons must be having a few sleepless nights as the countdown to August 31 accelerates.
If you do the maths the answer is most surely a resounding NO! The curse of the struck off dentist and his gang is set to strike again, once again a company in their charge looks to have runout of other folk’s cash. Here are the numbers which directly contradict what was stated when interims were published on 27 September 2024.
Yesterday I flagged up HERE why cash strapped Roquefort (ROQ) was a total bargepole stock and the shares duly slumped this morning. Now we have news of director share buying and this is another SELL signal.
Thanks to kind reader A, I bring you a page from this week’s Private Eye where it appears to recognize the good work done by this website even if it cannot actually spell our name. Poor Uncle Chris, who co-founded the Eye, will yet again spin in his grave. The article concerns the woes of struck off dentist Ajan Rejinald which we have exposed on this website and which the Eye is now regurgitating. As is always the case, but especially with the Novacyt (NCYT) trial looming, anyone owning shares in Rejinald’s Roquefort (ROQ) needs their head examining.
I have warned before that Roquefort Therapeutics (ROQ) is a Standard listed crock of shite that will end in tears for shareholders. I now ask the question of whether it is already technically insolvent? That matters given the stink around Ashington Innovation (ASHI).
Patricia Murray of Liverpool has written to the FCA over both Ashington Innovations (ASHI) and Roquefort Therapeutics (ROQ). How a serious regulator can ignore what follows defies belief. Both companies are clearly utterly uninvestable. Ms Murray writes:
Roquefort (ROQ) was a Standard List shell brought to market by the scumbags at Optiva as s shell in March 2021, raising a Bernie at 5p - I did warn folks about it HERE. Its shares are now suspended at 6.75p as it could not get its accounts out on time. But the history of the main player, CEO Ajan Reginald should be telling you that this is a monumental bargepole and everyone involved, from the FCA downwards should be highly concerned.
